T. Elverdi And A. Eskazan, "Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura.," Drug design, development and therapy , vol.13, pp.1251-1258, 2019
Elverdi, T. And Eskazan, A. 2019. Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura.. Drug design, development and therapy , vol.13 , 1251-1258.
Elverdi, T., & Eskazan, A., (2019). Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura.. Drug design, development and therapy , vol.13, 1251-1258.
Elverdi, Tuğrul, And AE Eskazan. "Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura.," Drug design, development and therapy , vol.13, 1251-1258, 2019
Elverdi, Tuğrul And Eskazan, AE. "Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura.." Drug design, development and therapy , vol.13, pp.1251-1258, 2019
Elverdi, T. And Eskazan, A. (2019) . "Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura.." Drug design, development and therapy , vol.13, pp.1251-1258.
@article{article, author={Tuğrul ELVERDİ And author={AE Eskazan}, title={Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura.}, journal={Drug design, development and therapy}, year=2019, pages={1251-1258} }